A Brian Davis - Net Worth and Insider Trading

A Brian Davis Net Worth

The estimated net worth of A Brian Davis is at least $16,061 dollars as of 2024-11-29. A Brian Davis is the CFO of Verrica Pharmaceuticals Inc and owns about 12,900 shares of Verrica Pharmaceuticals Inc (VRCA) stock worth over $16,061. Details can be seen in A Brian Davis's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that A Brian Davis has not made any transactions after 2021-06-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of A Brian Davis

To

A Brian Davis Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, A Brian Davis owns 4 companies in total, including Verrica Pharmaceuticals Inc (VRCA) , Strongbridge Biopharma PLC (SBBP) , and Tengion Inc (TNGNQ) among others .

Click here to see the complete history of A Brian Davis’s form 4 insider trades.

Insider Ownership Summary of A Brian Davis

Ticker Comapny Transaction Date Type of Owner
VRCA Verrica Pharmaceuticals Inc 2021-06-04 Chief Financial Officer
SBBP Strongbridge Biopharma PLC 2019-02-20 Chief Financial Officer
TNGNQ Tengion Inc 2013-03-04 Chf. Fin. Offr & VP Fin.
LIMIT LIMIT 2023-10-10 director

A Brian Davis Latest Holdings Summary

A Brian Davis currently owns a total of 1 stock. A Brian Davis owns 12,900 shares of Verrica Pharmaceuticals Inc (VRCA) as of June 4, 2021, with a value of $16,061.

Latest Holdings of A Brian Davis

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VRCA Verrica Pharmaceuticals Inc 2021-06-04 12,900 1.25 16,061

Holding Weightings of A Brian Davis


A Brian Davis Form 4 Trading Tracker

According to the SEC Form 4 filings, A Brian Davis has made a total of 2 transactions in Verrica Pharmaceuticals Inc (VRCA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Verrica Pharmaceuticals Inc is the acquisition of 5,000 shares on June 4, 2021, which cost A Brian Davis around $49,450.

Insider Trading History of A Brian Davis

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

A Brian Davis Trading Performance

GuruFocus tracks the stock performance after each of A Brian Davis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by A Brian Davis is 40.35%. GuruFocus also compares A Brian Davis's trading performance to market benchmark return within the same time period. The performance of stocks bought by A Brian Davis within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how A Brian Davis's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of A Brian Davis

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 26.02 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 25.05 LIMIT LIMIT LIMIT LIMIT LIMIT

A Brian Davis Ownership Network

Ownership Network List of A Brian Davis

No Data

Ownership Network Relation of A Brian Davis

Insider Network Chart

A Brian Davis Owned Company Details

What does Verrica Pharmaceuticals Inc do?

Who are the key executives at Verrica Pharmaceuticals Inc?

A Brian Davis is the Chief Financial Officer of Verrica Pharmaceuticals Inc. Other key executives at Verrica Pharmaceuticals Inc include director & President and CEO Ted White , Chief Commercial Officer Joe Bonaccorso , and General Counsel Christopher G. Hayes .

Verrica Pharmaceuticals Inc (VRCA) Insider Trades Summary

Over the past 18 months, A Brian Davis made no insider transaction in Verrica Pharmaceuticals Inc (VRCA). Other recent insider transactions involving Verrica Pharmaceuticals Inc (VRCA) include a net sale of 150,999 shares made by Ted White , a net sale of 130,386 shares made by Joe Bonaccorso , and a net sale of 124,941 shares made by Christopher G. Hayes .

In summary, during the past 3 months, insiders sold 0 shares of Verrica Pharmaceuticals Inc (VRCA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 533,677 shares of Verrica Pharmaceuticals Inc (VRCA) were sold and 2,260,199 shares were bought by its insiders, resulting in a net purchase of 1,726,522 shares.

Verrica Pharmaceuticals Inc (VRCA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Verrica Pharmaceuticals Inc Insider Transactions

No Available Data

A Brian Davis Mailing Address

Above is the net worth, insider trading, and ownership report for A Brian Davis. You might contact A Brian Davis via mailing address: C/o Verrica Pharmaceuticals Inc., 10 North High Street, Suite 200, West Chester Pa 19380.

Discussions on A Brian Davis

No discussions yet.